Position Papers
EAACI position papers formulate recommendations and aim to provide practical information that can assist clinicians in planning and carrying out investigations on a variety of topics regarding allergy, asthma and clinical immunology. These are the output of our EAACI Task Forces, Sections, Interest Groups and Working Groups. Discover a regularly updated selection of them here!
All Position Papers
Filter
What are you looking for?
-
Category
-
Year
-
Keywords
-
Author
-
Position Paper 14/07/2023Standardization of clinical outcomes used in allergen immunotherapy in allergic asthma: An EAACI position paper
- Kappen, J.
- Agache, I.
- et al
-
Position Paper 20/06/2023
Exercise and physical activity for asthma management: The European Academy of Allergy and Clinical Immunology perspective
- Price, O.J.
- Bonini, M.
- et al
-
Position Paper 08/06/2023
The Allergen Immunotherapy Adverse Events Registry: Setup & methodology of a European Academy of Allergy and Clinical Immunology taskforce project
- Asllani, J.
- ADER study group
- et al
-
Position Paper 02/06/2023
Adverse events in children and adolescents undergoing allergen immunotherapy for respiratory allergies—Report from the Allergen Immunotherapy Adverse Events Registry (ADER), a European Academy of Allergy and Clinical Immunology taskforce
- Asllani, J.
- ADER study group
- et al
-
Position Paper 16/05/2023
Allergy to stings and bites from rare or locally important arthropods: Worldwide distribution, available diagnostics and treatment
- Sturm, G.
- Antolin-Amerigo, D.
- et al
-
Position Paper 29/04/2023
The One Health approach for allergic diseases and asthma
- Jutel, M.
- Bernstein, J.
- et al
-
Position Paper 11/04/2023
Patient-centered digital biomarkers for allergic respiratory diseases and asthma: The ARIA-EAACI approach – ARIA-EAACI Task Force Report
- Bousquet, J.
- Amaral, R.
- et al
-
Position Paper 01/04/2023
European Academy of Allergy and Clinical Immunology position paper on endoscopic scoring of nasal polyposis
- Gevaert, P.
- Bachert, C.
- et al
-
Position Paper 13/01/2023
Preliminary pilot study results of the EAACI allergy educational needs in primary care pediatricians Task Force in managing allergic disorders
- Ryan, D.
- Angier, E.
- et al
-
Position Paper 01/01/2023
Pathogenesis, immunology, and immune-targeted management of the multisystem inflammatory syndrome in children (MIS-C) or pediatric inflammatory multisystem syndrome (PIMS): EAACI Position Paper
- Feleszko, W.
- Buddingh E.P.
- et al
-
Position Paper 01/01/2023
A practical toolbox for the effective transition of adolescents and young adults with asthma and allergies: An EAACI position paper
- Vazquez-Ortiz, M.
- Alviani, C.
- et al
-
Position Paper 01/11/2022
Fungal exposome, human health, and unmet needs: A 2022 update with special focus on allergy
- Vitte, J.
- Malinovschi, A.
- et al
-
Position Paper 01/11/2022
Role of dietary fiber in promoting immune health – An EAACI position paper
- Venter, C.
- Greenhawt, M.
- et al
-
Position Paper 01/10/2022
Omics technologies in allergy and asthma research: An EAACI position paper
- Radzikowska, U.
- Baerenfaller, K.
- et al
-
Position Paper 01/10/2022
Diagnosis and management of food allergy-associated gastroesophageal reflux disease in young children – EAACI position paper
- Meyer, R.
- Lozinsky A.C.
- et al
-
Position Paper 01/10/2022
Diagnosis and management of allergy and respiratory disorders in sport: An EAACI task force position paper
- Price, O.J.
- Bonini, M.
- et al
-
Position Paper 01/09/2022
Allergic and hypersensitivity conditions in non-specialist care: Flow diagrams to support clinical practice
- Ryan, D.
- Clark, E.
- et al
-
Position Paper 01/09/2022
AllergoOncology: Danger signals in allergology and oncology: A European Academy of Allergy and Clinical Immunology (EAACI) Position Paper
- Bergmann, C.
- Agache, I.
- et al
-
Position Paper 01/08/2022
Allergies and COVID-19 vaccines: An ENDA/ EAACI Position paper
- Barbaud, A.
- Arcolaci, A.
- et al
-
Position Paper 01/08/2022
COVID-19 vaccination in patients receiving allergen immunotherapy (AIT) or biologicals – EAACI recommendations
- Jutel, M.
- Palomares, O.
- et al
-
Position Paper 01/08/2022
Effects of non-steroidal anti-inflammatory drugs and other eicosanoid pathway modifiers on antiviral and allergic responses: EAACI task force on eicosanoids consensus report in times of COVID-19
- Sokolowska, M.
- Diamant, Z.
- et al
-
Position Paper 01/07/2022
Alpine Altitude Climate Treatment for severe and uncontrolled asthma: an EAACI Position Paper
- Fieten, K.B.
- Cogo, A.
- et al
-
Position Paper 01/07/2022
Cannabis-related allergies: an international overview and consensus recommendations
- Skypala, I.J.
- Brucker, H.
- et al
-
Position Paper 01/06/2022
EAACI position paper on the clinical use of the bronchial allergen challenge: Unmet needs and research priorities
- Agache, I.
- Antolin-Amerigo, D.
- et al
-
Position Paper 01/06/2022
Proposal of 0.5 mg of protein/100 g of processed food as threshold for voluntary declaration of food allergen traces in processed food-A first step in an initiative to better inform patients and avoid fatal allergic reactions: A GA²LEN position paper
- Zuberbier, T.
- Aberer, W.
- et al
-
Position Paper 01/04/2022
Perceptions of adolescents and young adults with allergy and/ or asthma and their parents on EAACI guideline recommendations about transitional care: A European survey
- Khaleva, E.
- Dunn Galvin, A.
- et al
-
Position Paper 01/02/2022
Hypersensitivity reactions to chemotherapy: an EAACI position paper
- Pagani, M.
- Alvarez-Cuesta, E.
- et al
-
Position Paper 01/02/2022
Current allergy educational needs in primary care. Results of the EAACI working group on primary care survey exploring the confidence to manage and the opportunity to refer patients with allergy
- Cabrera, M.
- Angier, E.
- et al
-
Position Paper 01/01/2022
Hypersensitivity reactions to biological agents: An EAACI position paper
- Bavbek, S.
- Alvarez-Cuesta, E.
- et al
-
Position Paper 01/01/2022
One Health: EAACI Position Paper on coronaviruses at the human-animal interface, with a specific focus on comparative and zoonotic aspects of SARS-CoV-2
- Korath, A.D.J.
- Janda, J.
- et al
-
Position Paper 01/01/2022
A multi-disciplinary approach to the diagnosis and management of allergic disease: An EAACI Task Force
- Vassilopoulou, E.
- Feketea, G.
- et al
-
Position Paper 01/01/2022
A European survey of management approaches in chronic urticaria in children: EAACI Paediatric Urticaria Taskforce
- Tsabouri, S.
- Arasi, S.
- et al
-
Position Paper 01/12/2021
Adherence to the Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) checklist in articles published in EAACI Journals: A bibliographic study
- Wiehn, E.
- Alvarez-Perea, A.
- et al
-
Position Paper 01/12/2021
Technical standards in allergen exposure chambers worldwide – an EAACI Task Force Report
- Pfaar, O.
- Bergmann, C.
- et al
-
Position Paper 01/11/2021
Health effects of exposure to chlorination by – products in swimming pools
- Couto, M.
- Bernard, A.
- et al
-
Position Paper 01/11/2021
Dangerous liaisons: bacteria, antimicrobial therapies and allergic diseases
- Tramper-Stranders, G.
- Ambrożej, D.
- et al
-
Position Paper 01/10/2021
An EAACI Task Force report on allergy to beta-lactams in children: Clinical entities and diagnostic procedures
- Blanca-Lopez, N.
- Atanaskovic-Markovic M.
- et al
-
Position Paper 01/10/2021
Management of anaphylaxis due to COVID-19 vaccines in the elderly
- Bousquet, J.
- Agache, I.
- et al
-
Position Paper 01/09/2021
Allergen immunotherapy: The growing role of observational and randomized trial “Real-World Evidence”
- Paoletti, G.
- di Bona, D.
- et al
-
Position Paper 01/07/2021
Differentiation of COVID-19 signs and symptoms from allergic rhinitis and common cold: An ARIA-EAACI-GA2LEN consensus
- Hagemann, J.
- Jutel, M.
- et al
-
Position Paper 01/06/2021
Allergen immunotherapy for respiratory allergy: quality appraisal of observational comparative effectiveness studies using the REal Life Evidence AssessmeNt Tool
- di Bona, D.
- K Chu, D.
- et al
-
Position Paper 01/06/2021
ARIA-EAACI statement on severe allergic reactions to COVID-19 vaccines – an EAACI-ARIA Position Paper
- Klimek, L.
- Akdis, C.A.
- et al
-
Position Paper 01/06/2021
EAACI statement on the diagnosis, management and prevention of severe allergic reactions to COVID-19 vaccines
- Sokolowska, M.
- Eiwegger, T.
- et al
-
Position Paper 01/05/2021
Practice parameters for diagnosing and managing iodinated contrast media hypersensitivity
- Torres, M.J.
- Böhm, I.
- et al
-
Position Paper 01/04/2021
Noninvasive and minimally invasive techniques for the diagnosis and management of allergic diseases
- Baumann, R.
- Untersmayr, E.
- et al
-
Position Paper 01/04/2021
Delayed hypersensitivity to antiepileptic drugs in children
- Mori, F.
- Blanca-Lopez, N.
- et al
-
Position Paper 01/03/2021
Management of patients with chronic rhinosinusitis during the COVID-19 pandemic-An EAACI position paper
- Klimek, L.
- Bousquet, J.
- et al
-
Position Paper 01/03/2021
Placebo effects in allergen immunotherapy – An EAACI Task Force Position Paper
- Pfaar, O.
- Agache, I.
- et al
-
Position Paper 01/03/2021
COVID-19 pandemic: Practical considerations on the organization of an allergy clinic-An EAACI/ ARIA Position Paper
- Pfaar, O.
- Jutel, M.
- et al
-
Position Paper 01/03/2021
ARIA-EAACI statement on asthma and COVID-19 (June 2, 2020)
- Bousquet, J.
- Akdis, C.A.
- et al
-
Position Paper 01/01/2021
Biologicals in atopic disease in pregnancy: An EAACI position paper
- Pfaller, B.
- Agache, I.
- et al
-
Position Paper 01/01/2021
Current perspective on eicosanoids in asthma and allergic diseases: EAACI Task Force consensus report, part I
- Sokolowska, M.
- Diamant, Z.
- et al
-
Position Paper 01/01/2021
Immune modulation via T regulatory cell enhancement: Disease-modifying therapies for autoimmunity and their potential for chronic allergic and inflammatory diseases—An EAACI position paper of the task force on immunopharmacology (TIPCO)
- Roth-Walter, F.
- Adcock, I.
- et al
-
Position Paper 01/12/2020
The development of birch pollen seasons over 30 years in Munich, Germany – An EAACI task force report
- Bergmann K.C.
- Buters J.
- et al
-
Position Paper 01/11/2020
Diagnosis and management of the drug hypersensitivity reactions in coronavirus disease 19: An EAACI position paper
- Akkor, A.
- Brockow, K.
- et al
-
Position Paper 01/11/2020
Gender and occupational allergy: Report from the task force of the EAACI Environmental and Occupational Allergy Interest Group
- Moscato G.
- Apfelbacher C.
- et al
-
Position Paper 01/11/2020
Considerations on biologicals for patients with allergic disease in times of the COVID-19 pandemic: An EAACI statement
- Vultaggio, A.
- Agache, I.
- et al
-
Position Paper 01/10/2020
Immunology of COVID-19: Mechanisms, clinical outcome, diagnostics, and perspectives – A report of the European Academy of Allergy and Clinical Immunology (EAACI)
- Sokolowska, M.
- Agache, I.
- et al
-
Position Paper 01/10/2020
Intranasal corticosteroids in allergic rhinitis in COVID-19 infected patients: An ARIA-EAACI statement
- Bousquet, J.
- Akdis, C.A.
- et al
-
Position Paper 01/09/2020
In-vivo diagnostic test allergens in Europe: A call to action and proposal for recovery plan – An EAACI position paper
- Klimek, L.
- Hoffmann, H.J.
- et al
-
Position Paper 01/08/2020
EAACI Research and Outreach Committee: Improving standards and facilitating global collaboration through a Research Excellence Network
- Shamji, M.H.
- Akdis, C.A.
- et al
-
Position Paper 01/07/2020
Handling of allergen immunotherapy in the COVID-19 pandemic: An ARIA-EAACI statement
- Klimek, L.
- Akdis, C.A.
- et al
-
Position Paper 01/07/2020
Respiratory diseases and allergy in farmers working with livestock: a EAACI position paper
- Sigsgaard, T.
- Basinas, I.
- et al
-
Position Paper 01/07/2020
AllergoOncology: ultra-low IgE, a potential novel biomarker in cancer – a Position Paper of the European Academy of Allergy and Clinical Immunology (EAACI)
- Ferastraoaru, D.
- Bax, H.J.
- et al
-
Position Paper 01/06/2020
Towards a more precise diagnosis of hypersensitivity to beta-lactams – an EAACI position paper
- Romano A.
- Atanaskovic-Markovic M.
- et al
-
Position Paper 01/05/2020
Pollen season is reflected on symptom load for grass and birch pollen-induced allergic rhinitis in different geographic areas – An EAACI Task Force Report
- Pfaar, O.
- Bastl K.
- et al
-
Position Paper 01/05/2020
Genetic variants associated with T cell-mediated cutaneous adverse drug reactions: A PRISMA-compliant systematic review – An EAACI position paper
- Oussalah A.
- Yip V.
-
Position Paper 01/04/2020
State-of-the-art in marketed adjuvants and formulations in Allergen Immunotherapy: A position paper of the European Academy of Allergy and Clinical Immunology (EAACI)
- Jensen-Jarolim E.
- Bachmann M.F.
- et al
-
Position Paper 01/03/2020
EAACI position paper on diet diversity in pregnancy, infancy and childhood: Novel concepts and implications for studies in allergy and asthma
- Venter, C.
- Greenhawt, M.
- et al
-
Position Paper 01/02/2020
The role of mobile health technologies in allergy care: An EAACI position paper
- Matricardi, P.
- Alvarez-Perea, A.
- et al
-
Position Paper 01/01/2020
Diagnosis and management of Non-IgE gastrointestinal allergies in breastfed infants – An EAACI Position Paper
- Meyer, R.
- Fleischer D.M.
- et al
-
Position Paper 01/01/2020
Benefits and harm of systemic steroids for short- and long-term use in rhinitis and rhinosinusitis: an EAACI position paper
- Hox, V.
- Jordens, A.
- et al
-
Position Paper 01/11/2019
Prioritizing research challenges and funding for allergy and asthma and the need for translational research – The European Strategic Forum on Allergic Diseases
- Agache, I.
- Annesi-Maesano, I.
- et al
-
Position Paper 01/10/2019
An EAACI position paper on the investigation of perioperative immediate hypersensitivity reactions
- Garvey L.H.
- Ebo, D.G.
- et al
-
Position Paper 01/10/2019
Food processing and occupational respiratory allergy- An EAACI position paper
- Jeebhay, M.
- Bang B.E.
- et al
-
Position Paper 01/10/2019
Toward clinically applicable biomarkers for asthma: An EAACI position paper
- Diamant, Z.
- Alving K.
- et al
-
-
Position Paper 01/08/2019
EAACI position paper: Influence of dietary fatty acids on asthma, food allergy, and atopic dermatitis
- Venter, C.
- Meyer, R.
- et al
-
Position Paper 01/06/2019
A EAACI drug allergy interest group survey on how European allergy specialists deal with β-lactam allergy
- Torres, M.J.
- Celik G.E.
- et al
-
Position Paper 01/06/2019
AllergoOncology: Microbiota in allergy and cancer – A European Academy for Allergy and Clinical Immunology position paper
- Untersmayr, E.
- Bax H.J.
- et al
-
Position Paper 01/05/2019
EAACI position paper: Comparing insect hypersensitivity induced by bite, sting, inhalation or ingestion in human beings and animals
- Pali-Schöll I.
- Blank S.
- et al
-
Position Paper 01/05/2019
Diagnosis and management of drug-induced anaphylaxis in children: An EAACI position paper
- Atanaskovic-Markovic M.
- Gomes E.
- et al
-
Position Paper 01/04/2019
Skin microdialysis: methods, applications and future opportunities – an EAACI position paper
- Baumann, K.Y.
- Church, M.K.
- et al
-
Position Paper 01/03/2019
Emerging concepts and challenges in implementing the exposome paradigm in allergic diseases and asthma: a Practall document
- Agache, I.
- Gern, J.
- et al
-
Position Paper 01/03/2019
Comparing biologicals and small molecule drug therapies for chronic respiratory diseases: An EAACI Taskforce on Immunopharmacology position paper
- Roth-Walter, F.
- Adcock, I.
- et al
-
Position Paper 01/01/2019
Diagnosis and management of NSAID-Exacerbated Respiratory Disease (N-ERD) – a EAACI position paper
- Kowalski M.L.
- Agache, I.
- et al
-
Position Paper 01/01/2019
The roadmap for the Allergology specialty and allergy care in Europe and adjacent countries. An EAACI position paper
- Fyhrquist, N.
- Bilò, M.B.
- et al
-
Position Paper 01/01/2019
EAACI position paper on how to classify cutaneous manifestations of drug hypersensitivity
- Brockow, K.
- Ardern-Jones, M.R.
- et al
-
Position Paper 01/10/2018
Allergen immunotherapy in people, dogs, cats and horses – differences, similarities and research needs
- Mueller, R.S.
- Jensen-Jarolim E.
- et al
-
Position Paper 01/09/2018
The urgent need for a harmonized severity scoring system for acute allergic reactions
- Muraro, A.
- Beyer, K.
- et al
-
Position Paper 01/08/2018
EAACI Position paper on the standardization of nasal allergen challenges
- Augé J.
- Agache, I.
- et al
-
Position Paper 01/08/2018
EAACI/ENDA Position Paper: Diagnosis and management of hypersensitivity reactions to non-steroidal anti-inflammatory drugs (NSAIDs) in children and adolescents
- Kidon, M.
- Blanca-Lopez, N.
- et al
-
Position Paper 01/06/2018
Influenza burden, prevention, and treatment in asthma – A scoping review by the EAACI Influenza in asthma task force
- Schwarze, J.
- Jha A.
- et al
-
Position Paper 01/04/2018
Emerging roles of innate lymphoid cells in inflammatory diseases: Clinical implications
- Kortekaas Krohn, I.
- Golebski K.
- et al
-
Position Paper 01/04/2018
Challenges in the implementation of the EAACI AIT guidelines: A situational analysis of current provision of allergen immunotherapy
- Ryan, D.
- Angier, E.
- et al
-
Position Paper 01/03/2018
The roadmap for allergology in Europe: The subspecialty of allergology as “stop-over” on the way to a full specialty. An EAACI position statement
- Eguiluz-Gracia, I.
- Gayraud J.
-
Position Paper 01/02/2018
AllergoOncology: Opposite outcomes of immune tolerance in allergy and cancer
- Jensen-Jarolim E.
- Bax H.J.
- et al
-
Position Paper 01/02/2018
Current practice of allergy diagnosis and the potential impact of regulation in Europe
- Cardona, V.
- Demoly, P.
- et al
No results
There are no matches to the filters you selected
